Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design

Jean‐Michel Molina, Béatrice Berçot, Lambert Assoumou, Emma Rubenstein, Michèle Algarté-Génin, Gilles Pialoux, Christine Katlama, Laure Surgers, Cécile Bébéar, N. Dupin, Moussa Ouattara, Laurence Slama, Juliette Pavie, Claudine Duvivier, Bénédicte Loze, Lauriane Goldwirt, Séverine Gibowski, Manon Ollivier, Jade Ghosn, Dominique Costagliola, Alexandre Aslan, Claire Pintado, Constance Delaugerre, Diane Ponscarme, Eve Dalle, Julie Chas, Martin Siguier, Romain Palich, Marc-Antoine Valentin, Yazdan Yazdanpanah, Karine Lacombe, Jean-Paul Viard, Jeremy Lourenco, Anne Rachline, Pierre Detruchis, Myriam Diemer, Laurene Azemar, Stephanie Landowski, Philippe Ometsguine, Martin Buisson, Philip Feliho, Antoine Bachelard, Bao Phung, Christophe Rioux, Caroline Proux, Sylvie Le Gac, Luminita Schneider, Aziza Charmak, Nadine Ktorza, Sophie Seang, Thibaut Orriere, Baptiste Sellem, Christia Palacios, Soraya Mebarki